Dravet syndrome in Sweden: a population-based study

Area of Science:

• Pediatric Neurology
• Clinical Genetics
• Epilepsy Research

Background:

• Dravet syndrome is a rare, severe genetic epilepsy with early-onset seizures.
• Understanding its epidemiology and clinical course is crucial for patient management.

Purpose of the Study:

• To determine the incidence and prevalence of Dravet syndrome in Sweden (2007-2011).
• To characterize associated neurological comorbidities, disease progression, and treatment outcomes.

Main Methods:

• Population-based study involving neuropaediatricians, genetic labs, and referral clinicians in Sweden.
• Data collection focused on patients with an electro-clinical profile matching Dravet syndrome.

Main Results:

• Estimated incidence: 1 in 33,000 live births; prevalence: 1 in 45,700 children (<18 years).
• Median age at seizure onset was 6 months; diagnosis at 3 years.
• SCN1A gene mutation found in 88%; 67% had intellectual disability; 60% had autism spectrum disorder.
• Add-on stiripentol showed variable efficacy in seizure reduction.

Conclusions:

• This is the first population-based study of Dravet syndrome in Sweden.
• Findings align with international data on incidence.
• The study underscores the severe, progressive nature of this genetic epilepsy syndrome.